Daily non-political popular news in brief.
Anti-anginal drug safe but not effective in reducing major cardiac events in ACS patients
04-24-2007 · EurekAlert!The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA.
Read more »
Keywords: anti-anginal, drug, safe, effective, reducing, major, cardiac, events, acs, patients, anti, anginal, event, patient
« Previous | Next »
Similar news on "Anti-anginal drug safe but not effective in reducing major cardiac events in ACS patients":
- Angioplasty reduces long-term cardiac risk among heart patients with 'silent' ischemia
05-08-2007 · EurekAlert!
When compared with intensive drug therapy, percutaneous coronary intervention (PCI, angioplasty) was more beneficial in reducing the long-term risk of major cardiac events among heart attack survivors with "silent ischemia," according to a study in the May 9 issue of JAMA.
Similar news · Read more »
- Initiative to improve heart failure care at nation's hospitals makes major gains
07-23-2007 · EurekAlert!
A national initiative designed to improve heart-failure patient care in hospitals proved effective at increasing hospital adherence to key quality-of-care performance measures and reducing the length of hospital stays for patients. It also resulted in favorable trends for in-hospital and post-discharge mortality rates.
Similar news · Read more »
- Studies led by Rhode Island Hospital confirm safety and efficacy
11-17-2006 · EurekAlert!
Following two studies of patients who were treated with cardiac stents, physicians at Rhode Island Hospital continue to recommend drug-eluting stents as a safe and effective treatment.
Similar news · Read more »
- Pre-operative high or low red blood cell count linked with poorer outcomes in older patients
06-12-2007 · EurekAlert!
Older patients with mild degrees of pre-operative anemia -- low red blood cell count -- or those with a very high red blood cell count have a higher risk of post-operative death or cardiac events following major noncardiac surgery, according to a study in the June 13 issue of JAMA.
Similar news · Read more »
- Risk and outcome similar for bypass surgery, drug-eluting stents
04-19-2007 · EurekAlert!
Drug-eluting stent therapy and bypass surgery for coronary artery disease have about the same risk for a major cardiac event within 30 days after the procedures, researchers reported at the American Heart Association's 8th annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology.
Similar news · Read more »
- Mayo Clinic shows therapy effective for reducing lupus flares
11-09-2007 · EurekAlert!
Mayo Clinic researchers have shown that an immunosuppressive drug used in organ transplant cases is effective in reducing flare-ups in patients with systemic lupus erythematosus. SLE results in inflammation of connective tissues and can involve the skin, joints and kidneys. Its cause is unknown. The findings were announced today at the annual meeting of the American College of Rheumatology in Boston.
Similar news · Read more »
- Overcrowded hospitals may risk adverse events on busiest days
04-23-2007 · EurekAlert!
Hospitals that operate at or over their capacity may be at increased risk of adverse events that injure patients, according to a study led by investigators from Massachusetts General Hospital and Brigham and Woman's Hospital. The report in the May issue of the journal Medical Care suggests that efforts to meet two primary challenges facing hospitals today -- reducing costs and improving patient safety -- may work against each other.
Similar news · Read more »
- Pairing medical therapy with coronary intervention fails to reduce heart disease deaths
03-26-2007 · EurekAlert!
Results of research presented today at the American College of Cardiology’s 56th Annual Scientific Session showed that percutaneous coronary interventions combined with optimal medical therapy (OMT) was no more effective than OMT alone in preventing heart attacks and other cardiac events among patients with coronary artery disease. The study will be simultaneously published in the New England Journal of Medicine and will appear in the April 12 print issue.
Similar news · Read more »
- Drug/intervention combinations offer benefit in severe CVD
03-26-2007 · EurekAlert!
While millions of Americans suffer from severe cardiac dysfunction, only about 3,000 heart transplants are possible each year. In the meantime, doctors are trying to identify new combinations of medicines and interventions that will increase survival rates among this high-risk population. Research presented today at the American College of Cardiology's 56th Annual Scientific Session offers new insight into the most effective therapies for patients with severe left ventricular dysfunction, cardiogenic shock and perioperative hypertension.
Similar news · Read more »
- Annals of Internal Medicine tip sheet for March 20, 2007
03-19-2007 · EurekAlert!
The following articles are featured in the upcoming Annals of Internal Medicine: "Flexible Use of Drugs with Close Patient Follow-up Can Successfully Control Rheumatoid Arthritis;" "Osteoporosis Drug Strengthens Bones in Men with Prostate Cancer," and "Experts Show Physicians How to Initiate and Carry Through Timely and Effective Discussions about Hospice with Dying Patients."
Similar news · Read more »
